NCT05644015 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Darby W, Bergeron P, Brown N, DeFoor M, Jones B
Escape Room Relay Race: "Go for the Gold" in Formative Assessment. J Nurs Educ. 2020 Nov 1;59(11):646-650. doi: 10.3928/01484834-20201020-09.
Roman P, Rodriguez-Arrastia M, Molina-Torres G, Marquez-Hernandez VV, Gutierrez-Puertas L, Ropero-Padilla C
The escape room as evaluation method: A qualitative study of nursing students' experiences. Med Teach. 2020 Apr;42(4):403-410. doi: 10.1080/014215

The Effect of the Education Given With the Escape Room Game on the Learning of Parenteral Drug Administration by Nursing Students.

Clinical trial NCT05644015 - References